| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VIVO | Common Stock | Award | +7.95K | +10.17% | 86K | Jan 31, 2023 | Direct | F1 | ||
| transaction | VIVO | Common Stock | Disposed to Issuer | -86K | -100% | 0 | Jan 31, 2023 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VIVO | Stock Option (Right to Buy) | Disposed to Issuer | -$143K | -10K | -100% | $14.34 | 0 | Jan 31, 2023 | Common Stock | 10K | $19.66 | Direct | F3 |
| transaction | VIVO | Stock Option (Right to Buy) | Disposed to Issuer | -$49.3K | -2.5K | -100% | $19.70 | 0 | Jan 31, 2023 | Common Stock | 2.5K | $14.30 | Direct | F4 |
| transaction | VIVO | Stock Option (Right to Buy) | Disposed to Issuer | -$188K | -12.1K | -100% | $15.52 | 0 | Jan 31, 2023 | Common Stock | 12.1K | $18.48 | Direct | F5 |
| transaction | VIVO | Stock Option (Right to Buy) | Disposed to Issuer | -$176K | -11.7K | -100% | $15.12 | 0 | Jan 31, 2023 | Common Stock | 11.7K | $18.88 | Direct | F6 |
Lourdes Weltzien is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
| Id | Content |
|---|---|
| F1 | Represents 7,945 shares of the Issuer's common stock awarded to the Reporting Person upon the vesting of a portion of an award of performance stock units ("PSUs") in connection with the closing of the transactions contemplated by the Merger Agreement (as defined below). |
| F2 | The shares were disposed of pursuant to the Agreement and Plan of Merger dated as of July 7, 2022 (the "Merger Agreement") by and among the Issuer and SD Biosensor, Inc., a corporation with limited liability organized under the laws of the Republic of Korea whereby, immediately prior to the effective time of the merger contemplated therein (the "Effective Time"), all issued and outstanding shares of Issuer common stock were converted into the right to receive $34.00 per share in cash and, when so converted, automatically cancelled. |
| F3 | The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment. |
| F4 | The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment. |
| F5 | The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment. |
| F6 | The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment. |